Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hu, H."" wg kryterium: Autor


Tytuł:
Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic surgery in lung adenocarcinoma patients.
Autorzy:
Zhang L; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Xu L; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Chen Z; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
You H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Hu H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
He H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 14; Vol. 19 (3), pp. e0297742. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Lung Neoplasms*/complications
MicroRNAs*/genetics
Chronic Pain*/genetics
Chronic Pain*/complications
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/complications
Humans ; Prospective Studies ; Quality of Life ; Thoracic Surgery, Video-Assisted/adverse effects ; Pain, Postoperative/genetics ; Pain, Postoperative/prevention & control ; Phenotype ; Pneumonectomy/adverse effects
Czasopismo naukowe
Tytuł:
Predicting lung cancer survival prognosis based on the conditional survival bayesian network.
Autorzy:
Zhong L; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. .; Hainan Center for Disease Control and Prevention, Institute for Prevention and Control of Tropical Diseases and Chronic Noninfectious Diseases, Haikou, Hainan, China. .
Yang F; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. .; Institute for Medical Dataology, Shandong University, Jinan, China. .
Sun S; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Wang L; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.; Institute for Medical Dataology, Shandong University, Jinan, China.
Yu H; Chongqing Key Laboratory of Computational Intelligence, Chongqing University of Posts and Telecommunications, Chongqing, China.
Nie X; School of Computer Science and Technology, Shandong Jianzhu University, Jinan, China.
Liu A; Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Xu N; Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Zhang L; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Zhang M; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Qi Y; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Ji H; Department of Thoracic Surgery, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Liu G; Department of Radiology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Zhao H; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, China.
Jiang Y; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Li J; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Song C; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Yu X; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Yang L; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Yu J; Department of Radiology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Feng H; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Guo X; The Department for Chronic and Non-communicable Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
Yang F; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China. .
Xue F; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. .; Institute for Medical Dataology, Shandong University, Jinan, China. .
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2024 Jan 22; Vol. 24 (1), pp. 16. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Humans ; Bayes Theorem ; Prognosis ; Calibration ; China/epidemiology
Czasopismo naukowe
Tytuł:
Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radical resection.
Autorzy:
Chen S; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yang S; School of Life Sciences, Fudan University, Shanghai, China.
Zhao Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Huang Q; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wu H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Hu H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Sun Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Xiang J; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Ye T; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Jan; Vol. 15 (3), pp. 258-265. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Male ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Neoplasm Invasiveness/pathology ; Chemotherapy, Adjuvant
Czasopismo naukowe
Tytuł:
Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion.
Autorzy:
Wang K; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Hu X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Chen Y; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Yi X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Han X; Department of Geriatrics, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Zhu D; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Zhu B; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Luo H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2024 Jan; Vol. 18 (1), pp. e13705. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Pleural Effusion, Malignant*/diagnosis
Pleural Effusion, Malignant*/genetics
Pleural Effusion, Malignant*/metabolism
Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Pleural Effusion*/diagnosis
Humans ; Carcinoembryonic Antigen/metabolism ; Biomarkers, Tumor/metabolism ; ErbB Receptors/genetics
Czasopismo naukowe
Tytuł:
Menthol induces apoptosis and inhibits proliferation and migration of nonsmall cell lung carcinoma in vitro and in vivo through Akt pathway.
Autorzy:
Liu Z; Department of Critical Care Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Li C; Department of Orthopaedics, Qilu Hospital of Shandong University, Shandong University Centre for Orthopaedics, Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinnan, China.; Trauma Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Mu L; Department of Vascular Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hu H; Department of Vascular Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qin X; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2023 Dec; Vol. 17 (12), pp. 1265-1275. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma*
Animals ; Mice ; Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Proto-Oncogene Proteins c-akt/pharmacology ; Menthol/pharmacology ; Mice, Nude ; Apoptosis ; Cell Proliferation ; Lung/pathology ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study.
Autorzy:
Gu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.; Department of Oncology, Yan'an Hospital of Traditional Chinese Medicine, Shaanxi, China.; Cancer Center of Peking University Third Hospital, Beijing, China.
Yu J; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.; Cancer Center of Peking University Third Hospital, Beijing, China.
Hu H; Department of Oncology, Yan'an Hospital of Traditional Chinese Medicine, Shaanxi, China.
Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Cao B; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.; Cancer Center of Peking University Third Hospital, Beijing, China.
Liang L; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.; Cancer Center of Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (31), pp. 3147-3160. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Tyrosine Kinase Inhibitors ; Cohort Studies ; ErbB Receptors ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Mutation ; Exons
Czasopismo naukowe
Tytuł:
Identification of 3'-terminal 2'-O-methylated miRNA in plasma as a novel diagnostic biomarker of NSCLC.
Autorzy:
Guo X; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.; Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Guo H; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Lu KC; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Yan X; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Chen J; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Wei Y; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Han J; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Sun W; Department of Oncology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Hu H; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Su Y; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Shen L; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Zhang Y; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.; Institute of Artificial Intelligence Biomedicine, Nanjing University, Nanjing, Jiangsu, China.
Yin K; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.; Department of General Surgery, Taixing Hospital Affiliated to Yangzhou University, Taixing, Jiangsu, China.
Zhang CY; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.; Institute of Artificial Intelligence Biomedicine, Nanjing University, Nanjing, Jiangsu, China.; Research Unit of Extracellular RNA, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China.; Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
Fu Z; Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, Institute of Artificial Intelligence Biomedicine, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.; Research Unit of Extracellular RNA, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Nov; Vol. 13 (11), pp. e1454.
Typ publikacji:
Letter
MeSH Terms:
MicroRNAs*/genetics
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Humans ; Biomarkers
Opinia redakcyjna
Tytuł:
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study.
Autorzy:
Huang J; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Xiao Y; Department of Cardio-Thoracic Surgery, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Zhou Y; Department of Cardio-Thoracic Surgery, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Deng H; Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yuan Z; The Second Clinical Medical College, Guangdong Medical University, Dongguan, Guangdong, China.
Dong L; The Second Clinical Medical College, Guangdong Medical University, Dongguan, Guangdong, China.
Lan J; Department of General Surgery, the People's Hospital of Gaoan City. Gaoan, Jiangxi, China.
Li X; Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Liu G; Department of Anesthesiology, Shenzhen Second People's Hospital, Guangzhou, China.
Hu H; Department of Radiation Therapy, General Hospital of Southern Theater Command, Guangzhou, Guangdong, China. .
Huang S; Department of Cardio-Thoracic Surgery, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. .
Yang X; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China. .; School of Medicine, South China University of Technology, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Aug 30; Vol. 23 (1), pp. 812. Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/therapy
Adenocarcinoma of Lung*
Carcinoma, Squamous Cell*
Humans ; Biomarkers, Tumor ; Carcinoembryonic Antigen ; Retrospective Studies ; CA-19-9 Antigen ; Immunotherapy ; CA-125 Antigen ; Carbohydrates
Czasopismo naukowe
Tytuł:
Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer.
Autorzy:
Xu X; Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.
Liu Y; Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.
Hu H; Department of Labor Health, School of Public Health, China Medical University, Shenyang, China.
Wang J; Department of Venereal Disease Prevention, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Cai Y; Department of Health Toxicology, School of Public Health, Xiamen University, Xiamen, China.
Xie J; Sanming Dermatology Hospital, Sanming, China.
Kang M; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China. .
He F; Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Aug 11; Vol. 21 (1), pp. 243. Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Journal Article
MeSH Terms:
Polymorphism, Single Nucleotide*
Lung Neoplasms*/genetics
Humans ; Quality of Life ; Genotype ; Prognosis ; Genetic Predisposition to Disease ; Case-Control Studies
Czasopismo naukowe
Tytuł:
Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter study.
Autorzy:
Zhou Y; Department of Cardio-Thoracic Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong; The University of Hongkong-ShenZhen Hospital, Shenzhen, 518000, China.
Huang J; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
Lan J; Department of General Surgery, the People's Hospital of Gaoan City. Gaoan, Jiangxi, China.
Hu H; Department of Radiation Therapy, General Hospital of Southern Theater Command, Guangzhou, Guangdong, China.
Yuan Z; The Second Clinical Medical College of Guangdong Medical University, Dongguan, Guangdong, China.
Dong L; The Second Clinical Medical College of Guangdong Medical University, Dongguan, Guangdong, China.
Deng H; Department of Anesthesiology, the Third Xiangya Hospital, Central South University, Chang-sha, Hunan, China.
Yue LA; Huafa Community Health Service Center, Shenzhen, Zhuhai, China.
Xiao Y; Department of Cardio-Thoracic Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Yang X; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi; School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Aug; Vol. 19 (4), pp. 1011-1018.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Epstein-Barr Virus Infections*/complications
Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/drug therapy
Lung Neoplasms*/therapy
Humans ; Propensity Score ; Herpesvirus 4, Human ; Immunotherapy ; Lung ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
Autorzy:
He J; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Lan X; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Liu X; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Deng C; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Luo H; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Wang Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Kang P; K2 Oncology Co., Ltd, Beijing, 100176, China.
Sun Z; K2 Oncology Co., Ltd, Beijing, 100176, China.
Zhao L; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China. .
Zhou X; Department of Respiratory medicine, The First Hospital Affiliated to Army Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 23; Vol. 23 (1), pp. 266. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Gefitinib/pharmacology ; Gefitinib/therapeutic use ; Blotting, Western ; Cell Proliferation ; Prognosis ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Causal associations between gastroesophageal reflux disease and lung cancer risk: A Mendelian randomization study.
Autorzy:
Li L; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ren Q; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zheng Q; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Bai Y; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
He S; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zhang Y; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ma H; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 7552-7559. Date of Electronic Publication: 2022 Dec 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/etiology
Lung Neoplasms*/genetics
Gastroesophageal Reflux*/complications
Gastroesophageal Reflux*/epidemiology
Gastroesophageal Reflux*/genetics
Humans ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; Causality ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors.
Autorzy:
Liang L; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Wang Z; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.; Department of Neurosurgery, Dongguan People's Hospital (Affiliated Dongguan Hospital, South Medical University), Dongguan 523058, China.
Duan H; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
He Z; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Lu J; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Jiang X; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Hu H; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Li C; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Yu C; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Zhong S; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Cui R; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Guo X; Department of Neurosurgery, The First Affiliated Hospital of Ji'nan University, Guangzhou 518053, China.
Deng M; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Chen Y; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Du X; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Wu S; Department of Radiotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Chen L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Mou Y; Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Feb 13; Vol. 30 (2), pp. 2227-2236. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/pathology
Brain Neoplasms*/secondary
Humans ; Aged ; Retrospective Studies ; ErbB Receptors ; Prognosis
Czasopismo naukowe
Tytuł:
Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China.
Autorzy:
Hu H; School of Management, Beijing University of Chinese Medicine, Beijing, China.
Zhao L; School of Management, Beijing University of Chinese Medicine, Beijing, China. .
Yong Y; Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
Nicholas S; Australian National Institute of Management and Commerce, Sydney, NSW, Australia.; Guangdong Institute for International Strategies, Guangdong University of Foreign Studies, Guangzhou, China.; School of Economics and School of Management, Tianjin Normal University, Tianjin, China.; Newcastle Business School, University of Newcastle, Callaghan, NSW, Australia.
Maitland E; University of Liverpool Management School, University of Liverpool, Liverpool, UK.
Zhao W; School of Management, Beijing University of Chinese Medicine, Beijing, China.
Yan H; School of Management, Beijing University of Chinese Medicine, Beijing, China.
Ma Y; China Health Insurance Research Association, Beijing, China.
Shi X; School of Management, Beijing University of Chinese Medicine, Beijing, China. .; National Institute of Traditional Chinese Medicine Strategy and Development, Beijing University of Chinese Medicine, Beijing, China. .
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Jan 26; Vol. 23 (1), pp. 89. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*
Insurance*
Humans ; Middle Aged ; Cross-Sectional Studies ; Hospitalization ; Length of Stay ; Health Expenditures ; China
Czasopismo naukowe
Tytuł:
The combination of MnO 2 @Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer.
Autorzy:
Zhang J; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Xu L; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Hu H; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Chen E; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 466-477.
Typ publikacji:
Journal Article
MeSH Terms:
Bevacizumab/*pharmacology
Carcinoma, Non-Small-Cell Lung/*pathology
Gefitinib/*pharmacology
Lung Neoplasms/*pathology
Manganese Compounds/*chemistry
Nanotubes/*chemistry
Oxides/*chemistry
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Bevacizumab/administration & dosage ; Cell Line, Tumor ; Cell Survival/drug effects ; Chemistry, Pharmaceutical ; Delayed-Action Preparations ; Drug Carriers/chemistry ; Drug Combinations ; Drug Liberation ; Gefitinib/administration & dosage ; Humans ; Hydrogen-Ion Concentration ; Mice ; Mice, Inbred BALB C ; Particle Size ; Surface Properties ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Biomarker-Targeted Therapies in Non-Small Cell Lung Cancer: Current Status and Perspectives.
Autorzy:
Guo H; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Chengdu University of TCM, Chengdu 610075, China.
Zhang J; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Zunyi Medical University, Zunyi 563003, China.
Qin C; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Zunyi Medical University, Zunyi 563003, China.
Yan H; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Zunyi Medical University, Zunyi 563003, China.
Liu T; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Zunyi Medical University, Zunyi 563003, China.
Hu H; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Zunyi Medical University, Zunyi 563003, China.
Tang S; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.
Tang S; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.
Zhou H; Department of Thoracic Surgery, Suining Central Hospital, Suining 629099, China.; Institute of Surgery, Graduate School, Chengdu University of TCM, Chengdu 610075, China.; Institute of Surgery, Graduate School, Zunyi Medical University, Zunyi 563003, China.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 12; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/metabolism
Humans ; Molecular Targeted Therapy ; Immunotherapy ; Biomarkers
Czasopismo naukowe
Tytuł:
The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma.
Autorzy:
Li Q; Department of Radiation Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.; Zhejiang Provincial Key Laboratory of Watershed Sciences and Health, Wenzhou Medical University, Wenzhou, 325035, China.; South Zhejiang Institute of Radiation Medicine and Nuclear Technology, Wenzhou Medical University, Wenzhou, 325035, China.; Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.
Zhang P; Department of Radiation Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.; Zhejiang Provincial Key Laboratory of Watershed Sciences and Health, Wenzhou Medical University, Wenzhou, 325035, China.; South Zhejiang Institute of Radiation Medicine and Nuclear Technology, Wenzhou Medical University, Wenzhou, 325035, China.; Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.
Hu H; Department of Radiation Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.; Zhejiang Provincial Key Laboratory of Watershed Sciences and Health, Wenzhou Medical University, Wenzhou, 325035, China.; South Zhejiang Institute of Radiation Medicine and Nuclear Technology, Wenzhou Medical University, Wenzhou, 325035, China.; Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.
Huang H; Department of Radiation Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.; Zhejiang Provincial Key Laboratory of Watershed Sciences and Health, Wenzhou Medical University, Wenzhou, 325035, China.; South Zhejiang Institute of Radiation Medicine and Nuclear Technology, Wenzhou Medical University, Wenzhou, 325035, China.; Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.
Pan D; Department of Dermatology, Duke University Medical Center, Durham, NC, 27710, USA.
Mao G; Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.
Hu B; Department of Radiation Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China. .; Zhejiang Provincial Key Laboratory of Watershed Sciences and Health, Wenzhou Medical University, Wenzhou, 325035, China. .; South Zhejiang Institute of Radiation Medicine and Nuclear Technology, Wenzhou Medical University, Wenzhou, 325035, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2022 Jul 15; Vol. 23 (1), pp. 190. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/therapy
Cell Cycle Checkpoints ; Chemoradiotherapy ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis
Czasopismo naukowe
Tytuł:
Application Effect of Dexmedetomidine and Dezocine in Patients Undergoing Lung Cancer Surgery under General Anesthesia and Analysis of Their Roles in Recovery Time and Cognitive Function.
Autorzy:
Ding J; Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Zhu M; Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Lv H; Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Zhang J; Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Chen W; Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Pokaż więcej
Źródło:
Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Jun 30; Vol. 2022, pp. 9889534. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2022).
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use
Dexmedetomidine*/therapeutic use
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Tetrahydronaphthalenes*/therapeutic use
Anesthesia, General ; Cognition ; Drug Combinations ; Humans
Czasopismo naukowe
Tytuł:
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice.
Autorzy:
Ma SC; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Bai X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guo XJ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu L; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Department of Medical Quality Management, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xiao LS; Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Lin Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Tan JL; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Cai XT; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wen YX; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ma H; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Fu QJ; Department of Community Health, Tufts University, Medford, USA.
Leng MX; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhang YP; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Long LL; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guo ZQ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. .
Zhou JG; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China. .; Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany. .; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. .
Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Apr 12; Vol. 20 (1), pp. 120. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*/pathology
B7-H1 Antigen ; Clinical Trials as Topic ; Humans ; Immunotherapy ; Progression-Free Survival
Czasopismo naukowe
Tytuł:
Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer.
Autorzy:
Xinli W; Department of Pathology, The Second Affiliated Hospital of Shandong First Medical University, Taian City, Shandong Province, China.
Lixiao W; Shandong First Medical University, Taian City, Shandong Province, China.
Baoqi D; Department of Pathology, The Second Affiliated Hospital of Shandong First Medical University, Taian City, Shandong Province, China.
Hu H; Department of Pathology, The Second Affiliated Hospital of Shandong First Medical University, Taian City, Shandong Province, China.
Qiang Z; Shandong First Medical University, Taian City, Shandong Province, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 Mar 30; Vol. 2022, pp. 1707914. Date of Electronic Publication: 2022 Mar 30 (Print Publication: 2022).
Typ publikacji:
Journal Article; Retracted Publication
MeSH Terms:
Carcinoid Tumor*
Carcinoma, Neuroendocrine*/pathology
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Squamous Cell*
Lung Neoplasms*/metabolism
Neuroendocrine Tumors*/pathology
Small Cell Lung Carcinoma*/diagnosis
Biomarkers, Tumor/metabolism ; Chromogranin A ; Humans ; SOXC Transcription Factors/genetics ; Transcription Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies